Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
OTW HOLDINGS LLC via CGCN GROUP, LLC
2026 · third_quarter · Q3
Issues related to maternal and infant health.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PARTNER THERAPEUTICS, INC. via CGCN GROUP, LLC
2026 · third_quarter · Q3
Source: Senate LDA
Issues related to medical countermeasures for Acute Radiation Syndrome (ARS).
Issues pertaining to the development of public health emergency medical countermeasures. Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2026 · third_quarter · Q3
Issues related to public health.
Issues related to domestic manufacturing.
Issues related to tariffs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI USA, LLC via CGCN GROUP, LLC
2026 · third_quarter · Q3
Section 232 investigation into pharmaceuticals and unfair trade practices.
U.S. manufacturing incentives.
Sec. 232 investigation on pharmaceutical sector, tariffs, Buy America policies, Most Favored Nations Executive Order, reciprocal tariffs, essential medicines drug shortages related to trade agreements.
Buy America legislation, tariffs, and tax incentives.
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
OTW HOLDINGS LLC via CGCN GROUP, LLC
2026 · third_quarter · RR
Issues related to maternal and infant health.
HEALTHY MOMS, HEALTHY BABIES AMERICA via CGCN GROUP, LLC
2026 · third_quarter · RA
Issues related to maternal and infant health.
2026 · third_quarter · RR
Issues related to public health and domestic manufacturing.
Issues related to public health and domestic manufacturing.
Issues related to public health and domestic manufacturing.
HEALTHY MOMS, HEALTHY BABIES AMERICA via CGCN GROUP, LLC
2026 · third_quarter · RR
Issues related to maternal and infant health.
HEARTLAND ACTION via CGCN GROUP, LLC
2026 · second_quarter · 2T
Issues related to maternal and infant health.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS KABI USA, LLC via CGCN GROUP, LLC
2026 · second_quarter · Q2
Section 232 investigation into pharmaceuticals and unfair trade practices.
U.S. manufacturing incentives.
Sec. 232 investigation on pharmaceutical sector, tariffs, Buy America policies, Most Favored Nations Executive Order, reciprocal tariffs, essential medicines drug shortages related to trade agreements.
Buy America legislation, tariffs, and tax incentives.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office